Samsrita Labs Intrinsic Value

SAMSRITA • Healthcare Services

Samsrita Labs (SAMSRITA) median intrinsic value is ₹8.00 from 1 valuation models (range ₹8–₹8), vs current price ₹17.35 — -53.9% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit SAMSRITA stock price BSE.

Current Stock Price
₹17.35
Primary Intrinsic Value
₹8.00
Market Cap
₹26.0 Cr
-53.9% Downside
Median Value
₹8.00
Value Range
₹8 - ₹8
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

SAMSRITA Valuation Methods Summary — DCF, Graham Number & P/E

Samsrita Labs intrinsic value across 1 models vs current price ₹17.35 — upside/downside and value range per method. Browse SAMSRITA cash flow statement for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹8.00 ₹7.20 - ₹8.80 -53.9% Book Value/Share: ₹8.00, P/B: 1.0x
Method Types: Earnings Asset DCF Growth Dividend Conservative

SAMSRITA Intrinsic Value vs Market Price — All Valuation Models

Samsrita Labs fair value range ₹8–₹8 vs current market price ₹17.35 across 1 valuation models. Compare with SAMSRITA fair value to assess whether the stock is under or overvalued.

SAMSRITA Intrinsic Value Analysis — Undervalued or Overvalued?

Samsrita Labs median intrinsic value ₹8.00, current price ₹17.35 — Trading Above Calculated Value by 53.9%, margin of safety -100.0%.

What is the intrinsic value of SAMSRITA?

Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Samsrita Labs (SAMSRITA) is ₹8.00 (median value). With the current market price of ₹17.35, this represents a -53.9% variance from our estimated fair value.

The valuation range spans from ₹8.00 to ₹8.00, indicating ₹8.00 - ₹8.00.

Is SAMSRITA undervalued or overvalued?

Based on our multi-method analysis, Samsrita Labs (SAMSRITA) appears to be trading above calculated value by approximately 53.9%.

SAMSRITA Financial Health — Key Ratios vs Industry Benchmarks

Samsrita Labs financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity -166.7% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency

SAMSRITA Cash Flow Quality — Operating & Free Cash Flow

Samsrita Labs operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2021 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10